Source: Pharmaceutical Executive

Signals Analytics: Signals Analytics Expands Rare Disease Data Coverage

Signals Analytics, analytics platform that leverages external data to uncover trends and predictive insights, announced the addition of 1,600 rare diseases, deepening its coverage of medical conditions and therapeutic areas. The enhancement of rare diseases coverage offers pharmaceutical c

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Gil Sadeh's photo - Co-Founder & CEO of Signals Analytics

Co-Founder & CEO

Gil Sadeh

CEO Approval Rating

85/100

Read more